News | October 09, 2014

Hologic Kicks Off National Breast Cancer Awareness Month by Ringing NASDAQ Opening Bell

President and CEO highlighted important benefits of 3-D Mammography solution for breast cancer screening and diagnosis

October 9, 2014 — Earlier this month Hologic President and CEO Stephen MacMillan presided over the NASDAQ stock market opening bell ceremony on Oct. 1, the first day of Breast Cancer Awareness Month.

In his remarks, MacMillan discussed the company’s campaign focused on the important benefits of Hologic’s 3-D mammography technology. This is the ninth consecutive year that Hologic has been invited to participate in the NASDAQ opening bell ceremony on the first business day in October.

“It is an honor to host the NASDAQ opening bell ceremony on the first day of Breast Cancer Awareness Month,” said MacMillan. “We are committed to developing technologies that detect diseases earlier and improve patient outcomes. Our 3D mammography technology addresses the limitations of traditional mammography – the over-diagnosis of noninvasive cancers and unnecessary recalls for additional testing – with the demonstrated ability to increase the detection rate of invasive cancers. It is the first and only 3-D system that is clinically proven to be superior to traditional 2-D mammography.”

Hologic was the first company to receive U.S. Food and Drug Administration (FDA) approval for its 3-D mammography system. This technology was approved for breast cancer screening and diagnosis in the United States in February 2011 and in countries recognizing CE mark since 2008. Hologic offers a comprehensive 3-D platform, including low-dose 3-D mammography, as well as the first FDA-approved 3-D guided breast biopsy system.

For more information: www.hologic.com

Related Content

Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...
American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines
News | Mammography | May 03, 2019
The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a...
Hologic Launches Trident HD Specimen Radiography System
Technology | Breast Biopsy Systems | April 26, 2019
Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Women With Coronary Artery Wall Thickness at Risk for Heart Disease
News | Cardiac Imaging | April 25, 2019
The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for...
The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.
GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...